muscarine has been researched along with sb 202190 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felder, CC; Mark, RJ; Ogden, AM; Segal, JA; Wood, MW | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
2 other study(ies) available for muscarine and sb 202190
| Article | Year |
|---|---|
Inflammatory cytokines enhance muscarinic-mediated arachidonic acid release through p38 mitogen-activated protein kinase in A2058 cells.
Topics: Animals; Anisomycin; Arachidonic Acid; Carbachol; Cerebellum; Cerebral Cortex; Cholinergic Agonists; Cytokines; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Inflammation Mediators; Interleukin-1; Mitogen-Activated Protein Kinases; Muscarine; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |